FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
0.9300
+0.0019 (0.20%)
At close: Oct 30, 2026, 4:00 PM EDT
0.9400
+0.0100 (1.08%)
After-hours: Oct 30, 2026, 7:30 PM EDT
FibroBiologics Employees
FibroBiologics had 15 employees as of December 31, 2025. The number of employees increased by 2 or 15.38% compared to the previous year. That makes FibroBiologics the 39,193rd largest employer in the world and 5,714th in the United States.
Employees
15
Change (1Y)
2
Growth (1Y)
15.38%
Revenue / Employee
n/a
Profits / Employee
-$1,209,267
Market Cap
6.47M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 15 | 2 | 15.38% |
| Dec 31, 2024 | 13 | 3 | 30.00% |
| Dec 31, 2023 | 10 | 3 | 42.86% |
| Sep 30, 2023 | 8 | 1 | 14.29% |
| Jun 30, 2023 | 7 | - | - |
| Dec 31, 2022 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| Processa Pharmaceuticals | 12 |
| Aprea Therapeutics | 8 |
| CNS Pharmaceuticals | 8 |
| MetaVia | 8 |
| Lexaria Bioscience | 7 |
| Enveric Biosciences | 6 |
| Alzamend Neuro | 6 |
FBLG News
- 12 days ago - FibroBiologics Presents Preclinical Data on Fibroblast Spheroid-Derived Chondrocyte Spheroids for Degenerative Disc Disease at the North American Spine Society 2026 Annual Meeting - PRNewsWire
- 17 days ago - FibroBiologics’ patent application accepted in Australia - TheFly
- 17 days ago - FibroBiologics Announces Australian Patent Accepted for Cellular Blend for the Regeneration of Chondrocytes and Cartilage Cells in Degenerated Spinal Discs - PRNewsWire
- 24 days ago - FibroBiologics files U.S. patent application covering, GLP-1, other peptides - TheFly
- 24 days ago - FibroBiologics Files Patent Application for Technology Designed to Produce GLP-1 and Other Therapeutic Peptides Inside the Body - PRNewsWire
- 4 weeks ago - FibroBiologics announces grant of European patent - TheFly
- 4 weeks ago - FibroBiologics Announces Grant of European Patent for Methods of Enhancing Fibroblast Therapeutic Activity - PRNewsWire
- 5 weeks ago - FibroBiologics Transcript: Investor update - Transcripts